Trials / Active Not Recruiting
Active Not RecruitingNCT03705806
Palliative Thoracic ImmunoRT
Evaluation of Toxicities With Thoracic Radiotherapy and Immune Checkpoint Inhibition in Non-small Cell Lung Cancer
- Status
- Active Not Recruiting
- Phase
- —
- Study type
- Observational
- Enrollment
- 12 (actual)
- Sponsor
- University Health Network, Toronto · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
The trial is designed as a prospective observational single arm study investigating stage IV non-small cell lung cancer patients who are routinely treated with a PD-1 inhibitor for indications approved by Health Canada. All patients who are selected will be referred for palliative thoracic radiotherapy and treated with a standard dose prescription of 30 Gy in 10 fractions.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| RADIATION | Radiation combined with immunotherapy | The trial is designed as a prospective observational single arm study investigating stage IV non-small cell lung cancer patients who are routinely treated with a PD-1 inhibitor for indications approved by Health Canada. All patients who are selected will be referred for palliative thoracic radiotherapy and treated with a standard dose prescription of 30 Gy in 10 fractions. |
Timeline
- Start date
- 2018-10-03
- Primary completion
- 2027-09-01
- Completion
- 2027-09-01
- First posted
- 2018-10-15
- Last updated
- 2026-03-04
Locations
1 site across 1 country: Canada
Source: ClinicalTrials.gov record NCT03705806. Inclusion in this directory is not an endorsement.